1427404-87-2 Usage
Uses
Used in Pharmaceutical Research and Development:
4-Bromo-pyrazolo[1,5-a]pyridine is used as a chemical building block for the synthesis of new drug candidates due to its unique structure and reactivity. It serves as a valuable component in the creation of novel compounds with potential therapeutic applications.
Used in Medical and Therapeutic Applications:
4-Bromo-pyrazolo[1,5-a]pyridine is used as a key component in the exploration of new chemical entities for various medical and therapeutic applications. Its ability to interact with certain biological receptors makes it a promising candidate for the development of treatments targeting specific diseases and conditions.
Used in Drug Synthesis:
4-Bromo-pyrazolo[1,5-a]pyridine is used as a starting material or intermediate in the synthesis of pharmaceutical compounds. Its unique chemical properties allow for the creation of diverse drug molecules with potential therapeutic effects.
Used in Biological Receptor Interaction Studies:
4-Bromo-pyrazolo[1,5-a]pyridine is used in research to study its interaction with biological receptors, providing insights into its potential therapeutic effects and mechanisms of action. This information can guide the development of new drugs with improved efficacy and safety profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 1427404-87-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,2,7,4,0 and 4 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1427404-87:
(9*1)+(8*4)+(7*2)+(6*7)+(5*4)+(4*0)+(3*4)+(2*8)+(1*7)=152
152 % 10 = 2
So 1427404-87-2 is a valid CAS Registry Number.
1427404-87-2Relevant articles and documents
Pyrimidine-4 (3H)-ketone heterocyclic compound, preparation method thereof and application of pyrimidine-4 (3H)-ketone heterocyclic compound in medicine
-
Paragraph 0183-0185; 0191-0194, (2021/07/21)
The invention relates to pyrimidine-4 (3H)-ketone heterocyclic compounds suitable for inhibiting or regulating SHP2, a preparation method of the pyrimidine-4 (3H)-ketone heterocyclic compounds and application of the pyrimidine-4 (3H)-ketone heterocyclic compounds in medicine. Specifically, the invention relates to a compound as shown in a general formula (I) and a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the compound or the pharmaceutically acceptable salt thereof, a method for treating and/or preventing related diseases mediated by SHP2, especially cancers by using the compound or the pharmaceutically acceptable salt thereof, and a preparation method of the compound or the pharmaceutically acceptable salt thereof. The invention also relates to application of the compound or the pharmaceutically acceptable salt thereof or a pharmaceutical composition containing the compound or the pharmaceutically acceptable salt thereof in preparation of drugs for treating and/or preventing SHP2-mediated related diseases. Wherein each substituent in the general formula (I) is as defined in the specification.
QUINOXALINE DERIVATIVES
-
, (2021/07/24)
The present invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
